Biora Therapeutics to reveal 00-size BioJet device at PODD meeting

Biora Therapeutics announced that Adi Mohanty, CEO, will present on the company’s 00-size BioJet device at the 14th Annual Partnership Opportunities in Drug Delivery meeting, taking place in Boston, October 28-29, 2024. “As part of the development of our clinical-ready BioJet device, we were able to reduce its size from 000 to 00, while slightly increasing the payload capacity,” said Mohanty. “Market research indicates a strong patient preference for a 00-size device, a preference that is shared by our pharma collaborators. We are excited about the progress we’ve made with this revolutionary, needleless, liquid injection technology in a smaller capsule that is readily accepted by patients. In addition to providing updates on our BioJet and NaviCap platforms, the PODD meeting also provides an opportunity to meet with a number of our existing pharma collaborators as we are in the process of expanding those relationships.”